Visiopharm Overview

  • Founded
  • 2001
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 86
Employees
  • Latest Deal Type
  • Later Stage VC
  • Investors
  • 6

Visiopharm General Information

Description

Developer of pioneering image analysis and precision pathology tools designed to support researchers, diagnostics, drug development, and the development of companion diagnostics. The company uses artificial intelligence and deep learning to deliver tissue data mining tools, precision results, standardization of tissue data, and improved productivity, the solutions are agnostic with respect to scanner format and can easily be integrated with digital infrastructure and workflows, enabling medical practitioners to operate on a wide variety of virtual slide microscopes.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Discovery Tools (Healthcare)
Biotechnology
Parent Company
Primary Office
  • Agern Allé 24
  • 2970 Hørsholm
  • Denmark
+45 88 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Visiopharm Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 01-Sep-2020 Completed Generating Revenue
3. Merger/Acquisition 02-Mar-2020 000.00 Completed Generating Revenue
2. Later Stage VC 23-Aug-2018 $15.5M $15.5M Completed Generating Revenue
1. Later Stage VC 05-Oct-2007 Completed Generating Revenue
To view Visiopharm’s complete valuation and funding history, request access »

Visiopharm Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of pioneering image analysis and precision pathology tools designed to support researchers, diagnostics, drug
Decision/Risk Analysis
Hørsholm, Denmark
86 As of 2020
000.00
0000000000 0

00000000

is nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dol
0000000000 000000000
Tolochenaz, Switzerland
00 As of 0000
000.00
000 0000-00-00
00000000000 000.00

000000 0

it esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt
00000 0000000000
NM
00 As of 0000
000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Visiopharm Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Lunaphore Technologies Venture Capital-Backed Tolochenaz, Switzerland 00 000.00 00000000000 000.00
000000 0000 Angel-Backed NM 00 000000000
To view Visiopharm’s complete competitors history, request access »

Visiopharm Executive Team (12)

Name Title Board Seat Contact Info
Michael Grunkin Ph.D Co-Founder, Chief Executive Officer, Managing Director & Board Member
Kristian Dalhof Nielsen Chief Financial Officer
Thomas Ahl Ph.D Chief Operating Officer
Johan Hansen Co-Founder, Chief Technical Officer & Board Member
Adrian Arechiga Ph.D Chief Marketing Officer
You’re viewing 5 of 12 executive team members. Get the full list »

Visiopharm Board Members (8)

Name Representing Role Since
Claus Møller MD The ATP Group Board Member 000 0000
Henrik Stender Ph.D Self Board Member 000 0000
Johan Hansen Visiopharm Co-Founder, Chief Technical Officer & Board Member 000 0000
Martin Bonde Ph.D Self Board Member 000 0000
Michael Grunkin Ph.D Visiopharm Co-Founder, Chief Executive Officer, Managing Director & Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Visiopharm Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Visiopharm Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000 0000000 01-Dec-2016 000000000000000000 Other Devices and Supplies 0000000 0000000 00.0
Digital Pathology Consultants 08-Dec-2012 Merger/Acquisition Consulting Services (B2B) 0000000 0000000 00.0
To view Visiopharm’s complete acquisitions history, request access »